SEC Form 4 · accession 0000914190-16-000610

Arno Therapeutics, Inc · ARNI

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chief Executive Officer & CMO · Director

Period of report

Apr 7, 2016

Accepted (ET)

Apr 11, 2016 · 4:20 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001195116

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	holding	—	—		—	261,832	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (right to buy)^F4	$0.37	Apr 7, 2016	A	1,196,070	A	—	Apr 7, 2026	Common Stock	1,196,070	1,196,070	D
Stock Option (right to buy)^F1	$2.40	holding	—	—	—	—	Jun 22, 2021	Common Stock	109,375	109,375	D
Stock Option (right to buy)^F1	$2.40	holding	—	—	—	—	Jun 22, 2021	Common Stock	55,736	55,736	D
Stock Option (right to buy)^F1	$2.40	holding	—	—	—	—	Jan 14, 2023	Common Stock	36,562	36,562	D
Stock Option (right to buy)^F1	$2.40	holding	—	—	—	—	Jan 14, 2023	Common Stock	12,187	12,187	D
Stock Option (right to buy)^F2	$2.40	holding	—	—	—	—	Nov 4, 2023	Common Stock	316,389	316,389	D
Stock Option (right to buy)^F3	$2.90	holding	—	—	—	—	Jan 24, 2024	Common Stock	711,301	711,301	D
2012 Series A Warrants (right to buy)	$1.36	holding	—	—	—	Nov 26, 2012	Nov 26, 2017	Common Stock	183,822	183,822	D
2013 Series D Warrants (right to buy)	$2.14	holding	—	—	—	Oct 29, 2013	Oct 29, 2018	Common Stock	77,880	77,880	D

F1Currently exercisable.
F2Vests in equal 36-monthly installments commencing 12/4/13.
F3Vests 25% on first anniversary date and thereafter will vest in 24 equal monthly installments.
F4Vests one-third on the first anniversary of grant and thereafter in 24 equal monthly installments.